Comments

Innate Pharma Stock Price, Quotes and Forecasts

Q: What sector and industry does Innate Pharma (IPHA) operate in?

Innate Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

IPHANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.87

At close: Jun 16 EDT

$1.90

0.031.60%

Pre-Market: 9:09 AM EDT

Innate Pharma (IPHA) Forecast

News Earnings Innate Pharma (IPHA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Innate Pharma Stock Price, Quotes and Forecasts | NASDAQ:IPHA | Benzinga

Explore Innate Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IPHA.

Open	-
Close	-
Volume / Avg.	0 / 24.00K
Day Range	- - -
52 Wk Range	1.29 - 3.51
Market Cap	$175.10M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	0.07%
Days to Cover	5.28

Recent News

French Drugmaker Sanofi Clocks 20% Q1 Profit Growth, Forecasts Strong Rebound In Annual Profit

Sanofi Q1 2025 revenue rose 10.8% to $10.42 billion, driven by Dupixent and new launches, as earnings climbed 20.1% and 2025 guidance was reaffirmed.

Vandana Singh

Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 24.00K
Day Range	- - -
52 Wk Range	1.29 - 3.51
Market Cap	$175.10M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	0.07%
Days to Cover	5.28

About Innate Pharma

Sector

Health Care

Industry

Biotechnology

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherap...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Innate Pharma (IPHA) stock?

You can purchase shares of Innate Pharma (NASDAQ:IPHA) through any online brokerage.

View our list of the best stock brokerages

Who are Innate Pharma (IPHA) competitors?

Other companies in Innate Pharma’s space includes: Cabaletta Bio (NASDAQ:CABA), 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and Sensei Biotherapeutics (NASDAQ:SNSE).

What is the forecast, or price target, for Innate Pharma (IPHA) stock?

Innate Pharma has a consensus price target of $10.67.

What is the current price for Innate Pharma (IPHA)?

The stock price for Innate Pharma (NASDAQ: IPHA) is $1.9 last updated June 16, 2025 at 9:09 AM EDT.

Does Innate Pharma (IPHA) pay a dividend?

There are no upcoming dividends for Innate Pharma.

When is Innate Pharma (NASDAQ:IPHA) reporting earnings?

Innate Pharma’s H1 earnings are confirmed for Thursday, September 11, 2025.

Is Innate Pharma (IPHA) going to split?

There is no upcoming split for Innate Pharma.

What sector and industry does Innate Pharma (IPHA) operate in?

Innate Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.